Abstract
The entity known today as the D-1 receptor was identified in the late 1960’s. These early studies utilized either the retina or the superior cervical ganglion of the cow (Kebabian and Greengard, 1971; Brown and Makman, 1972). In either of these tissues, dopamine stimulated the production of cyclic AMP. In either of these tissues, dopamine stimulated the production of cyclic AMP. In the case of the superior cervical ganglion, the use of bovine tissue was fortuitous: the bovine ganglion gave a much larger response to dopamine than the homologus structure in rats or rabbits (Cramer et al., 1973; Kalix et al., 1974; Williams et al. 1977). In the case of the retina, the response to dopamine was ubiquitous among common laboratory animals. Dopamine-stimulated accumulation of cAMP provided a convenient biochemical signal for determining the drug-recognition properties of the dopamine receptor. This approach was superior to the behavioral assays then in use to characterize the drug recognition properties of the then unitary dopamine receptor.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Altar, CA., Marien, M.R. (1987). Picomolar affinity of 125I-SCH 23982 for D1 receptors in brain demonstrated with digital subtraction autoradiography. J. Neurosci. 7: 213–222.
Amlaiky, N., Berger, J.G., Chang, W., McQuade, R.J. and Caron, M.G. (1987). Identification of the binding subunit of the D1-dopamine receptor by photoaffinity crosslinking. Mol. Pharmacol. 31: 129–134.
Andersen, P.H., Gronvald, F.C. and Jansen, J.A. (1985). A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatum. Life Sci. 37: 1971–1983.
Andersen, P.H., Nielsen, E.B., Scheel-Kruger, J., Jansen, J.A., and Hohlweg, R. (1987). Thienopyridine derivatives identified as the first selective, full efficacy, dopamine D1 receptor agonists. European J. Pharmacol. 137: 291–292.
Arnt, J. (1985). Hyperactivity induced by stimulation of separate dopamine D-1 and D-2 receptors in rats with bilateral 6-OHDA lesions. Life Sci. 37: 717–723.
Arnt, J. (1985). Differential effects of dopamine D-1 and D-2 agonists and antagonists in 6-hydroxydopamine-lesioned rats. Psychopharmacology [Suppl] 2: 60–61.
Arnt, J. (1985). Behavioral stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats. Eur. J. Pharmacol. 113: 79–88.
Billard, W., Ruperto, V., Crosby, G., lorio, L.C. and Barnett, A. (1984). Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum. Life Sci. 35: 1885–1893.
Boyson, S.J., McGonigle, P. and Molinoff, P.B. (1986). Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain. J. Neurosci. 6: 3177–3188.
Brown, E.M. and Aurbach, G.D. (1980). Role of cyclic nucleotides in secretory mechanisms and actions of parathyroid hormone and calcitonin. Vitarn Horm. 38: 205–256.
Brown, J.H. and Makman, M.H. (1972). Stimulation by dopamine of adenylate cyclase in retinal homogenates and of adenosine-3′: 5′-cyclic monophosphate formation in intact retina. Proc. Natl. Acad. Sci. USA 69: 539–543.
Cannon, J.G. (1985). Dopamine agonists: structure-activity relationships. Prog. Drug. Res. 29: 303–414.
Chen, T.C., Cote, T.E. and Kebabian, J.W. (1980). Endogenous components of the striatum confer dopamine-sensitivity upon adenylate cyclase activity: the role of endogenous guanyl nucleotides. Brain Res. 181: 139–149.
Clement-Cormier, Y.C., Parrish, R.G., Petzold, G.L., Kebabian, J.W., and Greengard, P. (1975). Characterization of a dopamine-sensitive adenylate cyclase in the rat caudate nucleus. J. Neurochem. 25: 143–149.
Cramer, H., Johnson, D.G., Hanbauer, I., Silberstein, S.D. and Kopin, I.J. (1973). Accumulation of adenosine 3′,5′-monophosphate induced by catecholamines in the rat superior cervical ganglion in vitro. Brain Res. 53: 97–104.
Dowling, J.E. (1987). The Retina. An approachable part of the brain. Harvard University Press.
Dowling, J.E. and Watling, K.J. (1981). Dopaminergic mechanisms in the teleost retina. II. Factors affecting the accumulation of cyclic AMP in pieces of intact carp retina. J. Neurochem. 36: 569–579.
Goldberg, L.I., Glock, D., Kohli, J.D. and Barnett, A. (1984). Separation of peripheral dopamine receptors by a selective DA1 antagonist, SCH 23390. Hypertension 6(2 Pt 2): 125–30.
Hyttel, J. (1981). Similarities between the binding of 3H-piflutixol and 3H-flupentixol to rat striatal dopamine receptors in vitro. Life Sci. 28: 563–569.
Iorio, L.C., Barnett, A., Leitz, F.H., Houser, V.P., Korduba, C.A. (1983) SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J. Pharmacol. Exp. Ther. 226: 462–468.
Jacobowitz, D.M. and Brown, E.M. (1980). Boving parathyroid catecholamines: a chemical and histochemical study. Experientia 36: 115–116.
Kaiser, C. and Jain, T. (1985). Dopamine receptors: Functions, subtypes and emerging concepts. Medicinal Research Quarterly 5: 145–229.
Kalix, P., McAfee, D.A., Schorderet, M. and Greengard P. (1974). Pharmacological analysis of synaptically mediated increase in cyclic adenosine monophosphate in rabbit superior cervical ganglion. J. Pharmacol. Exp. Ther. 188: 676–687.
Kebabian, J.W. and Calne, D.B. (1979). Multiple receptors for dopamine. Nature 277: 93–96.
Kebabian, J.W., Petzold, G.L. and Greengard P. (1972). Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the “dopamine receptor”. Proc. Natl. Acad. Sci. USA 69: 2145–2149.
Kebabian, J.W. and Greengard, P. (1971). Dopamine-sensitive adenyl cyclase: Possible role in synaptic transmission. Science 174: 1346–1349.
Mickevicius, C.K., Harrison, J.K. and Gnegy, M.E. (1986). Effect of cholera toxin on the activation of adenylate cyclase by calmodulin in bovine striaturn. Mol. Pharmacol. 30: 469–475.
Nielsen, M., Klimek, V. and Hyttel, J. (1984). Distinct target size of dopamine D-1 and D-2 receptors in rat striatum. Life Sci. 35: 325–332.
Niznik, H.B., Otsuka, N.Y., Dumbrille-Ross, A., Grigoriadis, D., Tirpak, A. and Seeman, P. (1986). Dopamine D1 receptors characterized with [3H]SCH 23390. Solubilization of a guanine nucleotide-sensitive form of the receptor. J. Biol. Chem. 261: 8397–8406.
Rodbell, M. (1980). The role of hormone receptors and GTP-regulatory proteins in membrain transduction. Nature 284: 17–22.
Ross, S.T., Franz, R.G., Gallagher, G., Brenner, M., Wilson, J.W., DeMarinis, R.M., Hieble, J.P. and Sarau, H.M. (1987). Dopamine agonists related to 3-allyl-6-chloro-2,3,4,5-tetrahydro-1-(4-hydroxyphenyl)-1H-3-benzazepine-7,8-diol. J. Med. Chem. 30: 35–40.
Setler, P.E., Sarau, H.M., Zirkle, C.L. and Saunders, H.L. (1978). The central effects of a novel dopamine agonist. Eur. J. Pharmacol. 50: 419–430.
Sidhu, A. and Fishman, P.H. (1986). Solubilization of the D-1 dopamine receptor from rat striatum. Biochem. Biophys. Res. Commun. 137: 943–949.
Sidhu, A., van Oene, J.C., Dandridge, P., Kaiser, C. and Kebabian, J.W. (1986). [125I]SCH 23982: The ligand of choice for identifying the D-1 dopamine receptor. Eur. J. Pharmacol. 128: 213–220.
Sidhu, A., and Kebabian, J.W. (1985). An iodinated ligand identifying the D-1 dopamine receptor. Eur. J. Pharmacol. 113: 437–440.
Teranishi, T., Negishi, K. and Kato, S. (1984). Dye coupling between amacrine cells in carp retina. Neurosci. Lett. 51: 73–78.
Teranishi, T., Negishi, K., and Kato, S. (1983). Dopamine modulates S-potential amplitude and dye-coupling between external horizontal cells in carp retina. Nature 301: 243–246.
Trugman, J.M. and Wooten, G.F. (1987). Selective D1 and D2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantia nigra lesions. J. Neurosci. 7: 2927–2935.
Watling, K.J. and Dowling, J.E. (1981). Dopaminergic mechanisms in the teleost retina. I. Dopamine-sensitive adenylate cyclase in homogenates of carp retina; effects of agonists, antagonists, and ergots. J. Neurochem. 36: 559–568.
Weinstock, J., Hieble, J.P., and Wilson J.W. (1985). The chemistry and pharmacology of 3-benzazepine derivatives. Drugs of the Future 10: 646–697.
Williams, T.H., Black, A.C., Jr., Chiba, T. and Jew, J.Y. (1977). Species differences in mammalian SIF cells. Adv. Biochem. Psychopharmacol. 16: 505–511.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer Science+Business Media New York
About this chapter
Cite this chapter
Kebabian, J.W. (1988). The D-1 Dopamine Receptor. In: Goldstein, M., Fuxe, K., Tabachnick, I. (eds) Central D1 Dopamine Receptors. Advances in Experimental Medicine and Biology, vol 235. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2723-1_2
Download citation
DOI: https://doi.org/10.1007/978-1-4899-2723-1_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-2725-5
Online ISBN: 978-1-4899-2723-1
eBook Packages: Springer Book Archive